Sepsis in neonates due to imipenemresistant Klebsiella pneumoniae producing NDM-1 in India

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1411-1413

  Roy, Subhasree ^a   Viswanathan, Rajlakshmi ^b   Singh, Arun K ^b   Das, Parijat ^a   Basu, Sulagna ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Carbapenem resistance; Neonatal intensive care unit; Neonatal sepsis; New Delhi metallo lactamase

Indexed keywords

3 AMINOBENZENEBORONIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BACTERIAL ENZYME; BENZENEBORONIC ACID; BETA LACTAM; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID; COLISTIN; DOXYCYCLINE; EDETIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; METALLO BETA LACTAMASE; MINOCYCLINE; NEW DELHI METALLO BETA LACTAMASE 1; QUINOLONE DERIVATIVE; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA-LACTAMASE NDM-1;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; DISK DIFFUSION; ENZYME ANALYSIS; HOSPITAL DISCHARGE; INDIA; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; NONHUMAN; PHENOTYPIC VARIATION; PLASMID; POLYMERASE CHAIN REACTION; TRACHEAL ASPIRATION PROCEDURE; TREATMENT DURATION; TREATMENT OUTCOME; BIOSYNTHESIS; CASE REPORT; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; SEPSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HUMANS; IMIPENEM; INDIA; INFANT, NEWBORN; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; SEPSIS;

EID: 79956015424     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr068     Document Type: Letter

References (9)

1. Black RE, Cousens S, Johnson HL, et al. Child health epidemiology reference group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet Infect Dis 2010; 375: 1969-87.
2. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53: 5046-54.
3. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
5. Woodford N, Tierno PM Jr, Young K, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 2004; 48: 4793-9.
6. Gröbner S, Linke D, Schütz W, et al. Emergence of carbapenem-nonsusceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tü bingen, Germany. J Med Microbiol 2009; 58: 912-22.
7. Munday CJ, Whitehead GM, Todd NJ, et al. Predominance and genetic diversity of community-and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J Antimicrob Chemother 2004; 54: 628-33.
8. Pé rez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
9. Hernandez-Alles S, Alberti S, Alvarez D, et al. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 1999; 145: 673-9.